-
A Modern Approach for Constructing Decision Analytic Models in Microsoft Excel
Mar 10, 2025, 14:00 PM -
Inequities in Access to Oncology Drugs in Brazil - the Case of Public and Private Healthcare Systems
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Pembrolizumab as First-Line Treatment for Patients with Microsatellite Instability High (MSI-H) or Mismatch Repair Deficient (dMMR) Unresectable or Metastatic Colorectal Cancer (CRC) from Public Payer Perspective in Brazil
Mar 10, 2025, 14:00 PM -
Is Every Peripheral Catheter the Same? Economic Burden and Budget Impact of Accidents and Phlebitis in Peripheral Venous Access According to Catheter Material and Safety Device
Mar 10, 2025, 14:00 PM -
Innovative Strategy for Resistant Depression and Suicidal Ideation: HEOR Analysis From the Perspective of BRAZIL / LATAM / LMIC .
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Pembrolizumab in 1L Recurrent/Metastatic Head and Neck Squamous Cell Cancer (R/M HNSCC) in Brazil
Mar 10, 2025, 14:00 PM -
Examination of Different Segments of Health Literacy and Health Awareness Among Pregnant Women
Mar 10, 2025, 14:00 PM -
The Evolution of Value-Based Agreements in US Healthcare: Barriers, Opportunities, and Future Prospects
Mar 10, 2025, 14:00 PM -
Real-World Patient Persistence and Adherence: A Comparison Of Long Acting Injectables and Oral Antipsychotics Used For The Treatment Of Schizophrenia in a Canadian Adult population
Mar 10, 2025, 14:00 PM -
Correlation and Predictors of EORTC QLQ-C30 GHS-QoL and EQ-5D VAS in Patients With Advanced NSCLC
Mar 10, 2025, 14:00 PM -
Exploring the Health and Well-being of Pediatric Caregivers within Chinese Cultural Contexts: A Systematic Review of Qualitative Studies from Chinese Databases
Mar 10, 2025, 14:00 PM -
Incidence of Opioid Use Disorder and the Associated Economic Burden Among People Managing Acute Pain With Prescription Opioids in the United States in Commercial, Medicare, and Medicaid Populations
Mar 10, 2025, 14:00 PM -
Chimeric Antigen Receptor T Cell (CAR T) Therapy As Second-Line (2L) Treatment for Patients With Relapsed/Refractory Large B-Cell Lymphoma (R/R LBCL): Therapy Choice and Treatment Barriers Among US Oncologists
Mar 10, 2025, 14:00 PM -
Microbiology Testing and Oral Antibiotic Treatment Among CKD Patients With Urinary Tract Infections: Real-World Evidence From a US EMR Network
Mar 10, 2025, 14:00 PM -
Racial and Ethnic Disparities in Orphan Drug Utilization Among Medicare Beneficiaries
Mar 10, 2025, 14:00 PM -
Impact of Chemotherapy and Demographic Factors on Survival in Adult (21-64-Year-Old) with Acute Lymphoblastic Leukemia: A SEER Database 10-Year Cohort Study
Mar 10, 2025, 14:00 PM -
Digital Health Interventions and Environmental Sustainability: A Targeted Literature Review
Mar 10, 2025, 14:00 PM -
Effectiveness of Early Remdesivir Initiation in Patients with Immunocompromising Conditions Hospitalized with COVID-19 by Variant Era, Level of Immunocompromise, and Age
Mar 10, 2025, 14:00 PM -
Maximizing the Impact of In-Trial Interviews Through AI Assisted Analysis
Mar 10, 2025, 14:00 PM -
Predictor of dispensing behavior for mental health treatments in Saudi Arabia
Mar 10, 2025, 14:00 PM
